Valiant Organics Grants 19,500 Employee Stock Options Under ESOP Scheme 2022
Valiant Organics Limited's NRC approved the grant of 19,500 employee stock options under ESOP Scheme 2022 on May 16, 2026, at an exercise price of Rs. 10/- per option. Of the total, 15,000 options vest after a minimum period of 1 year, with the remainder subject to performance criteria. The scheme complies with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and was disclosed under Regulation 30 of SEBI LODR Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Valiant Organics Limited's Nomination and Remuneration Committee (NRC) of the Board of Directors convened on Saturday, May 16, 2026, and approved the grant of 19,500 (Nineteen Thousand Five Hundred) employee stock options to eligible employees under the Valiant Employees Stock Option Plan 2022 ("ESOP Scheme"). The grant has been made in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company disclosed this development to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Details of the ESOP Grant
The following table summarises the key parameters of the stock option grant as disclosed in Annexure-I filed with the exchanges:
| Parameter: | Details |
|---|---|
| Total Options Granted: | 19,500 |
| Total Equity Shares Covered: | 19,500 |
| Exercise Price: | Rs. 10/- per option |
| Face Value per Share: | Rs. 10/- each |
| Conversion Ratio: | 1 option = 1 equity share |
| Exercise Period: | Within 3 years from date of vesting |
| Options Exercised: | Nil |
| Options Lapsed: | Nil |
| Money Realised by Exercise: | Nil |
Vesting Structure
The 19,500 options granted carry a structured vesting schedule as determined by the NRC. Of the total options granted, 15,000 options shall vest upon completion of a minimum vesting period of 1 year. The remaining options are subject to vesting upon achievement of specified performance criteria, as determined by the NRC in accordance with the applicable ESOP Scheme.
Once vested, each option entitles the holder to acquire one equity share of Valiant Organics upon payment of the exercise price. The exercise price shall in no event be less than the face value of the share, as prescribed under the scheme terms.
Scheme Administration and Compliance
The ESOP Scheme is administered by the NRC of the Board of Directors. The grant of options is based on eligibility criteria as defined under the scheme. The NRC determines the exercise price subject to conformity with applicable accounting policies. The scheme is in terms of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Key highlights of the scheme's governance framework include:
- The NRC oversees administration and eligibility determination
- Exercise price is set at Rs. 10/- per option, consistent with the face value
- Diluted earnings per share pursuant to the issue of equity shares on exercise of options is not yet applicable, as options are yet to be exercised
- No subsequent changes, cancellations, or variations to option terms have been reported
The intimation was signed by Kaustubh Kulkarni, Company Secretary (ICSI M. No: A52980), on behalf of Valiant Organics Limited.
Historical Stock Returns for Valiant Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.98% | +4.89% | -4.62% | +6.07% | -37.83% | -82.07% |
How might the exercise price of Rs. 10 per option — set at face value and significantly below current market price — impact employee retention and the potential dilution effect on existing shareholders?
What performance criteria has Valiant Organics' NRC set for the remaining options beyond the 15,000 time-based vesting tranche, and how will achievement be measured?
Could this ESOP grant signal Valiant Organics' plans for expansion or talent acquisition in specific business segments, and what strategic initiatives might the company be preparing for?


































